Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering

被引:11
作者
Luo, Jiesi [1 ,2 ]
Lin, Yuyao [1 ,2 ,3 ]
Shi, Xiangyu [1 ,2 ,4 ]
Li, Guangxin [5 ,6 ]
Kural, Mehmet H. [7 ,8 ]
Anderson, Christopher W. [1 ,2 ,7 ,9 ]
Ellis, Matthew W. [1 ,2 ,10 ]
Riaz, Muhammad [1 ,2 ]
Tellides, George [5 ,7 ]
Niklason, Laura E. [2 ,5 ,7 ,8 ]
Qyang, Yibing [1 ,2 ,7 ,9 ]
机构
[1] Yale Cardiovasc Res Ctr, Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06511 USA
[2] Yale Stem Cell Ctr, New Haven, CT 06520 USA
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian 710061, Shaanxi, Peoples R China
[4] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha 410011, Hunan, Peoples R China
[5] Yale Univ, Dept Surg, New Haven, CT 06520 USA
[6] China Med Univ, Hosp 1, Dept Vasc Surg, Shenyang 110122, Peoples R China
[7] Yale Univ, Vasc Biol & Therapeut Program, Sch Med, New Haven, CT 06520 USA
[8] Yale Univ, Dept Anesthesiol, New Haven, CT 06519 USA
[9] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA
[10] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06519 USA
关键词
Human induced pluripotent stem cells; vascular smooth muscle cells; xenogeneic-free; vascular tissue engineering; GROWTH-FACTOR-BETA; HUMAN FIBROBLASTS; SYNTHETIC GRAFT; IN-VITRO; VESSELS; SERUM; DERIVATION; INHIBITION; ANTIBODIES; SUBTYPES;
D O I
10.1016/j.actbio.2020.10.042
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Development of mechanically advanced tissue-engineered vascular grafts (TEVGs) from human induced pluripotent stem cell (hiPSC)-derived vascular smooth muscle cells (hiPSC-VSMCs) offers an innovative approach to replace or bypass diseased blood vessels. To move current hiPSC-TEVGs toward clinical application, it is essential to obtain hiPSC-VSMC-derived tissues under xenogeneic-free conditions, meaning without the use of any animal-derived reagents. Many approaches in VSMC differentiation of hiPSCs have been reported, although a xenogeneic-free method for generating hiPSC-VSMCs suitable for vascular tissue engineering has yet to be established. Based on our previously established standard method of xenogeneic VSMC differentiation, we have replaced all animal-derived reagents with functional counterparts of human origin and successfully derived functional xenogeneic-free hiPSC-VSMCs (XF-hiPSC-VSMCs). Next, our group developed tissue rings via cellular self-assembly from XF-hiPSC-VSMCs, which exhibited comparable mechanical strength to those developed from xenogeneic hiPSC-VSMCs. Moreover, by seeding XF-hiPSC-VSMCs onto biodegradable polyglycolic acid (PGA) scaffolds, we generated engineered vascular tissues presenting effective collagen deposition which were suitable for implantation into an immunodeficient mice model. In conclusion, our xenogeneic-free conditions for generating hiPSC-VSMCs produce cells with the comparable capacity for vascular tissue engineering as standard xenogeneic protocols, thereby moving the hiPSC-TEVG technology one step closer to safe and efficacious clinical translation. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:155 / 168
页数:14
相关论文
共 61 条
[1]   Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future [J].
Astori, Giuseppe ;
Amati, Eliana ;
Bambi, Franco ;
Bernardi, Martina ;
Chieregato, Katia ;
Schaefer, Richard ;
Sella, Sabrina ;
Rodeghiero, Francesco .
STEM CELL RESEARCH & THERAPY, 2016, 7
[2]   iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome [J].
Atchison, Leigh ;
Abutaleb, Nadia O. ;
Snyder-Mounts, Elizabeth ;
Gete, Yantenew ;
Ladha, Alim ;
Ribar, Thomas ;
Cao, Kan ;
Truskey, George A. .
STEM CELL REPORTS, 2020, 14 (02) :325-337
[3]   A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells [J].
Atchison, Leigh ;
Zhang, Haoyue ;
Cao, Kan ;
Truskey, George A. .
SCIENTIFIC REPORTS, 2017, 7
[4]  
Avogaro A., Diabetes Care
[5]   cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications [J].
Baghbaderani, Behnam Ahmadian ;
Tian, Xinghui ;
Neo, Boon Hwa ;
Burkall, Amy ;
Dimezzo, Tracy ;
Sierra, Guadalupe ;
Zeng, Xianmin ;
Warren, Kim ;
Kovarcik, Don Paul ;
Fellner, Thomas ;
Rao, Mahendra S. .
STEM CELL REPORTS, 2015, 5 (04) :647-659
[6]   Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates [J].
Bajpai, Vivek K. ;
Mistriotis, Panagiotis ;
Loh, Yuin-Han ;
Daley, George Q. ;
Andreadis, Stelios T. .
CARDIOVASCULAR RESEARCH, 2012, 96 (03) :391-400
[7]  
Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
[8]   Directed differentiation of embryonic origin-specific vascular smooth muscle subtypes from human pluripotent stem cells [J].
Cheung, Christine ;
Bernardo, Andreia S. ;
Pedersen, Roger A. ;
Sinha, Sanjay .
NATURE PROTOCOLS, 2014, 9 (04) :929-938
[9]   Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility [J].
Cheung, Christine ;
Bernardo, Andreia S. ;
Trotter, Matthew W. B. ;
Pedersen, Roger A. ;
Sinha, Sanjay .
NATURE BIOTECHNOLOGY, 2012, 30 (02) :165-173
[10]   Readily Available Tissue-Engineered Vascular Grafts [J].
Dahl, Shannon L. M. ;
Kypson, Alan P. ;
Lawson, Jeffrey H. ;
Blum, Juliana L. ;
Strader, Justin T. ;
Li, Yuling ;
Manson, Roberto J. ;
Tente, William E. ;
DiBernardo, Louis ;
Hensley, M. Taylor ;
Carter, Riley ;
Williams, Tiare P. ;
Prichard, Heather L. ;
Dey, Margaret S. ;
Begelman, Keith G. ;
Niklason, Laura E. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (68)